OTCMKTS:CLPBY

Coloplast A/S Q2 2025 Earnings Results & Report

Coloplast A/S logo
$7.35 -0.13 (-1.77%)
As of 03:56 PM Eastern

Coloplast A/S missed analyst expectations on both earnings and revenue in its Q2 2025 results, released May 6, 2025. The company reported EPS of $0.06 versus the $0.0874 consensus estimate, while revenue of $1.05 billion fell short of the $7.02 billion estimate by $5.97 billion.

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens

Coloplast A/S EPS Results

Actual EPS
$0.06
Consensus EPS
$0.0874
Beat/Miss
Missed by -$0.0274
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 8 quarters

Coloplast A/S Revenue Results

Actual Revenue
$1.05 billion
Expected Revenue
$7.02 billion
Beat/Miss
Missed by -$5.97 billion
YoY Revenue Growth
N/A

Upcoming Earnings

Coloplast A/S' next earnings date is estimated for Friday, February 5, 2027, based on past reporting schedules.

Conference Call Resources

Coloplast A/S Q2 2025 Earnings FAQ

Coloplast A/S (OTCMKTS:CLPBY) reported earnings of $0.06 per share for Q2 2025, missing the consensus estimate of $0.0874. The report was announced on Tuesday, May 6, 2025.

Coloplast A/S reported revenue of $1.05 billion for Q2 2025, against a consensus estimate of $7.02 billion.

Coloplast A/S' next earnings date is estimated for Friday, February 5, 2027. MarketBeat tracks confirmed and estimated earnings dates for Coloplast A/S on the company's earnings history page.

Coloplast A/S Earnings Headlines

Coloplast A/S (CLPBY) Q4 2026 Earnings Call Transcript
Buy Stocks… A Crash is Coming
Think stocks are expensive and a crash is coming? Economist Jim Rickards says you're right, but he urges investors not to sell before hearing his 2027 prediction. He warns that by November 30th, Congress is set to make a move he believes will trigger a historic buying panic. Economists call the phenomenon a crack-up boom. Rickards is known for correctly predicting the biggest market shocks of the last 20 years.tc pixel
CLPBY Share News Today
See More Coloplast A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Coloplast A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coloplast A/S and other key companies, straight to your email.

About Coloplast A/S

Coloplast A/S (OTCMKTS:CLPBY) is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care.

Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.

Founded in Denmark in 1957, Coloplast serves customers in markets around the world. The company was established after nurse Elise Sørensen helped develop an ostomy bag for her sister, in collaboration with entrepreneur Aage Louis-Hansen.

View Coloplast A/S Profile